annual D&A:
$2.78M+$675.00K(+32.13%)Summary
- As of today (May 29, 2025), RNA annual depreciation & amortization is $2.78 million, with the most recent change of +$675.00 thousand (+32.13%) on December 31, 2024.
- During the last 3 years, RNA annual D&A has risen by +$2.14 million (+334.43%).
- RNA annual D&A is now at all-time high.
Performance
RNA Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$785.00K+$47.00K(+6.37%)Summary
- As of today (May 29, 2025), RNA quarterly depreciation & amortization is $785.00 thousand, with the most recent change of +$47.00 thousand (+6.37%) on March 31, 2025.
- Over the past year, RNA quarterly D&A has increased by +$144.00 thousand (+22.46%).
- RNA quarterly D&A is now at all-time high.
Performance
RNA quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$2.92M+$144.00K(+5.19%)Summary
- As of today (May 29, 2025), RNA TTM depreciation & amortization is $2.92 million, with the most recent change of +$144.00 thousand (+5.19%) on March 31, 2025.
- Over the past year, RNA TTM D&A has increased by +$569.00 thousand (+24.20%).
- RNA TTM D&A is now at all-time high.
Performance
RNA TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
RNA Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +32.1% | +22.5% | +24.2% |
| 3 y3 years | +334.4% | +150.0% | +245.6% |
| 5 y5 years | +697.7% | +845.8% | +763.9% |
RNA Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +334.4% | at high | +150.0% | at high | +245.6% |
| 5 y | 5-year | at high | +697.7% | at high | +960.8% | at high | +801.2% |
| alltime | all time | at high | +697.7% | at high | +960.8% | at high | +3039.8% |
RNA Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $785.00K(+6.4%) | $2.92M(+5.2%) |
| Dec 2024 | $2.78M(+32.1%) | $738.00K(+3.9%) | $2.78M(+4.6%) |
| Sep 2024 | - | $710.00K(+3.3%) | $2.65M(+5.7%) |
| Jun 2024 | - | $687.00K(+7.2%) | $2.51M(+6.7%) |
| Mar 2024 | - | $641.00K(+4.2%) | $2.35M(+11.9%) |
| Dec 2023 | $2.10M(+51.5%) | $615.00K(+8.7%) | $2.10M(+12.5%) |
| Sep 2023 | - | $566.00K(+7.0%) | $1.87M(+11.7%) |
| Jun 2023 | - | $529.00K(+35.3%) | $1.67M(+14.1%) |
| Mar 2023 | - | $391.00K(+2.6%) | $1.46M(+5.6%) |
| Dec 2022 | $1.39M(+117.1%) | $381.00K(+3.0%) | $1.39M(+14.3%) |
| Sep 2022 | - | $370.00K(+14.9%) | $1.21M(+19.0%) |
| Jun 2022 | - | $322.00K(+2.5%) | $1.02M(+20.7%) |
| Mar 2022 | - | $314.00K(+51.0%) | $845.00K(+32.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $639.00K(+71.3%) | $208.00K(+18.2%) | $639.00K(+17.0%) |
| Sep 2021 | - | $176.00K(+19.7%) | $546.00K(+15.9%) |
| Jun 2021 | - | $147.00K(+36.1%) | $471.00K(+18.3%) |
| Mar 2021 | - | $108.00K(-6.1%) | $398.00K(+6.7%) |
| Dec 2020 | $373.00K(+7.2%) | $115.00K(+13.9%) | $373.00K(+9.4%) |
| Sep 2020 | - | $101.00K(+36.5%) | $341.00K(+5.2%) |
| Jun 2020 | - | $74.00K(-10.8%) | $324.00K(-4.1%) |
| Mar 2020 | - | $83.00K(0.0%) | $338.00K(-2.9%) |
| Dec 2019 | $348.00K(-9.1%) | $83.00K(-1.2%) | $348.00K(+31.3%) |
| Sep 2019 | - | $84.00K(-4.5%) | $265.00K(+46.4%) |
| Jun 2019 | - | $88.00K(-5.4%) | $181.00K(+94.6%) |
| Mar 2019 | - | $93.00K | $93.00K |
| Dec 2018 | $383.00K | - | - |
FAQ
- What is Avidity Biosciences annual depreciation & amortization?
- What is the all time high annual D&A for Avidity Biosciences?
- What is Avidity Biosciences annual D&A year-on-year change?
- What is Avidity Biosciences quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Avidity Biosciences?
- What is Avidity Biosciences quarterly D&A year-on-year change?
- What is Avidity Biosciences TTM depreciation & amortization?
- What is the all time high TTM D&A for Avidity Biosciences?
- What is Avidity Biosciences TTM D&A year-on-year change?
What is Avidity Biosciences annual depreciation & amortization?
The current annual D&A of RNA is $2.78M
What is the all time high annual D&A for Avidity Biosciences?
Avidity Biosciences all-time high annual depreciation & amortization is $2.78M
What is Avidity Biosciences annual D&A year-on-year change?
Over the past year, RNA annual depreciation & amortization has changed by +$675.00K (+32.13%)
What is Avidity Biosciences quarterly depreciation & amortization?
The current quarterly D&A of RNA is $785.00K
What is the all time high quarterly D&A for Avidity Biosciences?
Avidity Biosciences all-time high quarterly depreciation & amortization is $785.00K
What is Avidity Biosciences quarterly D&A year-on-year change?
Over the past year, RNA quarterly depreciation & amortization has changed by +$144.00K (+22.46%)
What is Avidity Biosciences TTM depreciation & amortization?
The current TTM D&A of RNA is $2.92M
What is the all time high TTM D&A for Avidity Biosciences?
Avidity Biosciences all-time high TTM depreciation & amortization is $2.92M
What is Avidity Biosciences TTM D&A year-on-year change?
Over the past year, RNA TTM depreciation & amortization has changed by +$569.00K (+24.20%)